Coding Bio

Engineering Modular Immunotherapies

Oxford, United Kingdom · Founded 2021

Headquarters
Oxford
Employees
11–50
Founded
2021
Business Model
B2B
Website
coding.bio
Last Round
SeedNov 2022
Rounds
1

About

Coding Bio is an Oxford-based biotechnology company that merges biology and computer science to engineer best-in-class immunotherapies for cancer patients. The company combines high-throughput cellular screening—testing millions of protein candidates in living cells—with a generative machine learning platform that analyzes protein structures to optimize therapy designs beyond simple binding affinity. Founded in 2021 by Simon Bornschein and Yulia Lampi, Coding Bio focuses on CAR and BiTE modular therapies, enabling partners to advance treatments to the clinic in months rather than years.

Summary

Coding Bio is an Artificial Intelligence company based in Oxford, United Kingdom, founded in 2021. Its most recent funding was a Seed round in Nov 2022. Investors include 2048 Ventures, Divergent Capital and Myeloma Investment Fund.

Tech & App Stack

2 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundNov 2022

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Coding Bio on Indexed.vc
<a href="https://indexed.vc/companies/coding-bio"><img src="https://indexed.vc/api/badge/company/coding-bio" alt="Coding Bio on Indexed.vc" width="260" height="76" /></a>